Mood after stroke: a case control study of biochemical, neuro-imaging and socio-economic risk factors for major depression in stroke survivors

被引:40
作者
Chatterjee, Kausik [1 ]
Fall, Susan [2 ]
Barer, David [2 ]
机构
[1] Countess Chester Hosp, Dept Stroke Med, Chester CH2 1UL, Cheshire, England
[2] Queen Elizabeth Hosp, Stroke Res Team, Gateshead NE9 6SX, England
关键词
WHITE-MATTER HYPERINTENSITIES; SMALL VESSEL DISEASE; PLASMA HOMOCYSTEINE; SYMPTOMS; COGNITION; DEMENTIA; ADULTS; SCALE; LIFE;
D O I
10.1186/1471-2377-10-125
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Though vascular factors may be important in the aetiology of late-life depression, it is not clear whether they have a major effect on the risk of depression after a stroke. We investigated the relationship between physiological, biochemical, neuro-imaging and socio-economic factors and late-phase post-stroke depression in a cross-sectional case-control study. Methods: People living at home at least 9 months after a stroke were interviewed using a structured proforma. Depression was diagnosed according to DSM-IV criteria, together with a Montgomery Asberg (MADRS) score >17. Stroke survivors of similar age and functional status but without symptoms of, or recent treatment for, depression and with MADRS score <7, were recruited as controls. Results: Stroke survivors with depression were more likely than controls to have been smokers, to have had hypertension or peripheral arterial disease, and to have had more than one stroke or multiple discrete brainscan lesions. In univariate analysis they had significantly higher blood pressure, lower Mini-Mental State (MMSE) scores, higher serum homocysteine and lower folate levels, as well as more extensive white matter and basal ganglia changes on brainscan. In logistic regression, previous hypertension (OR 3.4), peripheral vascular disease (OR 4.7), number of strokes (OR 2), MMSE score (OR 0.76) and basal ganglia changes (OR 2.2), were independently associated with depression. Conclusion: These results suggest that patients with hypertension, hyperhomocysteinaemia and other factors associated with cerebral small vessel disease, may be more susceptible to post-stroke depression. Future intervention trials should focus on such high risk groups.
引用
收藏
页数:10
相关论文
共 37 条
  • [31] Homocysteine and post-stroke cognitive decline
    Rowan, Elise N.
    Dickinson, Heather O.
    Stephens, Sally
    Ballard, Clive
    Kalaria, Raj
    Kenny, Rose Anne
    [J]. AGE AND AGEING, 2007, 36 (03) : 339 - 343
  • [32] Case-control studies: research in reverse
    Schulz, KF
    Grimes, DA
    [J]. LANCET, 2002, 359 (9304) : 431 - 434
  • [33] Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
    Seshadri, S
    Beiser, A
    Selhub, J
    Jacques, PF
    Rosenberg, IH
    D'Agostino, RB
    Wilson, PWF
    Wolf, PA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07) : 476 - 483
  • [34] Taylor M J., 2003, Cochrane Database of Systematic Reviews, DOI [10.1002/14651858.CD003390, 10.1002/ 14651858.CD003390, DOI 10.1002/14651858.CD003390]
  • [35] Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death - The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial
    Toole, JF
    Malinow, MR
    Chambless, LE
    Spence, JD
    Pettigrew, LC
    Howard, VJ
    Sides, EG
    Wang, CH
    Stampfer, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (05): : 565 - 575
  • [36] Wade D T, 1988, Int Disabil Stud, V10, P64
  • [37] A new rating scale for age-related white matter changes applicable to MRI and CT
    Wahlund, LO
    Barkhof, F
    Fazekas, F
    Bronge, L
    Augustin, M
    Sjögren, M
    Wallin, A
    Ader, H
    Leys, D
    Pantoni, L
    Pasquier, F
    Erkinjuntti, T
    Scheltens, P
    [J]. STROKE, 2001, 32 (06) : 1318 - 1322